Therefore, we evaluated the serum level of neurofilament light-chain (NF-L), as this has been validated as a biomarker for neurodegenerative diseases, disease progression, survival and death of large myelinated neurons, including motor neurons41. Here, NEFL is linked to neurodegenerative disease.